Editorials: Passage of stem cell bill a victory of science

The New York Times and The Washington Post called passage by the Senate of an unrestrictive embryonic stem cell bill a win for American science, but said its likely veto means science will still be denied the support of federal funding that should be freed for the research. The Times also said a White House-supported companion to the embryonic stem cell bill, also passed by the Senate, was a "poorly considered proposal."

View Full Article in:

NYTimes.com · Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX